{
  "actions": [
    {
      "acted_at": "2005-11-18", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2005-11-18", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to House Energy and Commerce", 
      "type": "referral"
    }, 
    {
      "acted_at": "2005-11-18", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to House Ways and Means", 
      "type": "referral"
    }, 
    {
      "acted_at": "2005-12-16", 
      "in_committee": null, 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr4395-109", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }, 
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }
  ], 
  "congress": "109", 
  "cosponsors": [
    {
      "district": "15", 
      "name": "Hinojosa, Ruben", 
      "sponsored_at": "2006-01-31", 
      "state": "TX", 
      "thomas_id": "01490", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "9", 
      "name": "Lee, Barbara", 
      "sponsored_at": "2006-01-31", 
      "state": "CA", 
      "thomas_id": "01501", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "21", 
      "name": "McNulty, Michael R.", 
      "sponsored_at": "2006-02-07", 
      "state": "NY", 
      "thomas_id": "00785", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "11", 
      "name": "Owens, Major R.", 
      "sponsored_at": "2006-01-31", 
      "state": "NY", 
      "thomas_id": "00883", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "6", 
      "name": "Woolsey, Lynn C.", 
      "sponsored_at": "2006-02-07", 
      "state": "CA", 
      "thomas_id": "01242", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2005-11-18", 
  "number": "4395", 
  "official_title": "To amend titles XVIII and XIX of the Social Security Act to provide for an improved voluntary Medicare prescription drug benefit, to provide greater access to affordable pharmaceuticals, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Medicare Prescription Drug Affordability Act of 2005", 
  "sponsor": {
    "district": "14", 
    "name": "Conyers, John, Jr.", 
    "state": "MI", 
    "thomas_id": "00229", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2005-11-18", 
  "subjects": [
    "Access to health care", 
    "Administrative fees", 
    "Administrative procedure", 
    "Antibiotics", 
    "Business records", 
    "Coinsurance", 
    "Commerce", 
    "Compensation (Law)", 
    "Congress", 
    "Congressional reporting requirements", 
    "Consumer discounts", 
    "Cost control", 
    "Cost effectiveness", 
    "Department of Health and Human Services", 
    "Drug advertising", 
    "Drug industry", 
    "Drug interactions", 
    "Drugs", 
    "Economics and public finance", 
    "Electronic funds transfers", 
    "Employee health benefits", 
    "Federal advisory bodies", 
    "Finance and financial sector", 
    "Foreign trade and international finance", 
    "Generic drugs", 
    "Government operations and politics", 
    "Government paperwork", 
    "Government publications", 
    "Government publicity", 
    "Government trust funds", 
    "Grievance procedures", 
    "Health", 
    "Health counseling", 
    "Health insurance continuation", 
    "Health maintenance organizations", 
    "Housing and community development", 
    "Import restrictions", 
    "Imports", 
    "Insurance premiums", 
    "Intellectual property", 
    "Labeling", 
    "Labor and employment", 
    "Law", 
    "Managed care", 
    "Marketing", 
    "Medicaid", 
    "Medical economics", 
    "Medical fees", 
    "Medical records", 
    "Medical savings accounts", 
    "Medicare", 
    "Medicare Payment Advisory Commission", 
    "Medigap", 
    "Packaging", 
    "Patents", 
    "Performance measurement", 
    "Pharmaceutical research", 
    "Pharmacies", 
    "Pharmacists", 
    "Physicians", 
    "Prescription pricing", 
    "Privatization", 
    "Product counterfeiting", 
    "Public service advertising", 
    "Quality of care", 
    "Research and development", 
    "Retiree health benefits", 
    "Rural health", 
    "Science, technology, communications", 
    "Social welfare", 
    "Standards", 
    "State laws", 
    "Subsidies"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2005-11-18", 
    "text": "Medicare Prescription Drug Affordability Act of 2005 - Amends title XVIII (Medicare) of the Social Security Act to revise part D (Voluntary Prescription Drug Benefit Program) as added by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, to provide for: (1) no premium; (2) no deductible; (3) coinsurance at a rate of 10%; (4) a $1,500 annual limit on out-of-pocket spending on covered drugs; and (5) reduced cost-sharing for lower-income individuals.\n\nRevises the Medigap program and the membership and duties of the Medicare payment advisory commission.\n\nPharmaceutical Market Access Act of 2005 - Amends the Federal Food, Drug and Cosmetic Act to: (1) repeal certain sections of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 relating to importation of prescription drugs from Canada; and (2) restore previous law, amended to direct the Secretary of Health and Human Services to allow qualifying individuals (in addition to pharmacists and wholesalers) to import covered products.\n\nRepeals the mandate that the Secretary require a foreign seller to specify the original source of the product and the amount of each product lot originally received. \n \n Amends requirements for the testing of imported covered products. \n \n Classifies prescription drugs as misbranded if they do not incorporate specified counterfeit-resistant technologies in packaging. \n \n Establishes a permanent bipartisan Quality Control and Cost Containment Blue Ribbon Task Force. \n \n Repeals the Comparative Cost Adjustment Program and prohibits the application of law in a manner that prevents a Medicare beneficiary from continuing to obtain benefits under a traditional fee-for-service Medicare program. \n \n Amends SSA title XVIII to repeal the Medicare Advantage Regional Plan Stabilization Fund. \n \n Repeals Health Savings Accounts. \n \n Provides for application of risk adjustment reflecting characteristics for the entire Medicare population. \n \n Directs the Secretary to make a specified phased-in adjustment of payment rates to Medicare+Choice payment organizations. \n \n Repeals the Medicare expenditure cap. \n \n Provides for continuous open enrollment in Medicare Advantage Plans."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Medicare Prescription Drug Affordability Act of 2005", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": true, 
      "title": "Pharmaceutical Market Access Act of 2005", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend titles XVIII and XIX of the Social Security Act to provide for an improved voluntary Medicare prescription drug benefit, to provide greater access to affordable pharmaceuticals, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2014-12-10T13:45:01-05:00"
}